Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020

SELL
$72.34 - $84.0 $13.3 Million - $15.4 Million
-183,500 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$62.63 - $80.22 $10 Million - $12.8 Million
-160,000 Reduced 46.58%
183,500 $13.7 Million
Q3 2018

Nov 06, 2018

BUY
$71.28 - $78.92 $19.1 Million - $21.1 Million
267,500 Added 351.97%
343,500 $26.5 Million
Q2 2017

Aug 08, 2017

BUY
N/A
76,000
76,000 $5.38 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cincinnati Insurance CO Portfolio

Follow Cincinnati Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cincinnati Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Cincinnati Insurance CO with notifications on news.